The ins/ins homozygosity within the NF-κB1 gene, associated with increased promoter activity (and thus a higher expression of proinflammatory cytokines), was more frequently detected among RA patients with inefficient response to anti-TNF treatment (39% vs. 17%, p = 0.047). The gene discussed is NFKB1; the disease is rheumatoid arthritis.